Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 58047.9 | nM | 10785416 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 1.5 | nM | 9548881 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 11.3 | nM | 20704331 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 9.1 | nM | 18590312 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 52.4 | nM | 23691978 |
NPT3955 | Individual Protein | Cannabinoid CB2 receptor | Rattus norvegicus | Activity | = | 46 | % | 23734701 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 12.3 | nM | 11720540 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | IC50 | = | 15.7 | nM | 17524651 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.9 | nM | 8277313 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 8.8 | nM | 26654828 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 79.43 | nM | 22342628 |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 18492.7 | nM | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.3 | nM | 26636180 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | 26636180 |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 11220.2 | nM | 11421731 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 6.06 | nM | DrugMatrix in vivo data: Pathology |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 89.6 | nM | DrugMatrix in vivo data: Pathology |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 4.92 | nM | DrugMatrix in vivo data: Hematology |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 2.8 | umol/kg | 24601675 |
NPT6282 | Individual Protein | Chaperonin GroEL (Thermosome, HSP60 family) | Methanococcus maripaludis (strain S2 / LL) | Potency | 100000 | nM | 16203143 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.1 | nM | 23819826 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 14.8 | nM | 12670149 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.3 | nM | 25734623 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.3 | nM | 15730257 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 40.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Ratio Ki | = | 2.74 | 22280481 | ||
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 0.43 | nM | 16513348 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 4.95 | nM | PubChem BioAssay data set |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 22459211 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 45.6 | nM | 23683594 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2 | nM | 15711537 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.07 | 23398362 | ||
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 39810.7 | nM | 22694318 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 50.12 | nM | 24893224 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 9.1 | nM | 25871540 |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 17.8 | nM | 3236010 |
NPT3955 | Individual Protein | Cannabinoid CB2 receptor | Rattus norvegicus | Ki | = | 7.73 | nM | 7908950 |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | 18198839 | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 107 | nM | 12880316 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Activity | = | 61 | % | 19284743 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | 20515062 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 45.6 | nM | 17980607 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 200 | nM | 22916954 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 4.53 | nM | 26859776 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 15387665 |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | 10346942 | ||
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.21 | mg/kg | 15217273 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.3 | nM | 17822299 |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 32629.4 | nM | 19674906 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 14 | nM | 16005211 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 140 | nM | 16005211 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 36.2 | nM | 23252848 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 180 | nM | 17306980 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 186208713.7 | nM | 17306980 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Activity | = | 47.1 | % | 17132069 |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 6 | nM | 19403307 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 86 | nM | 18694944 |
NPT2 | Others | Unspecified | Ratio Ki | = | 10 | 20797808 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 74 | % | 20421401 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 150 | nM | 20566771 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 2 | nM | 22578509 |
NPT3955 | Individual Protein | Cannabinoid CB2 receptor | Rattus norvegicus | EC50 | = | 1.5 | nM | 22541068 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Activity | = | 108 | % | 21920636 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12.5 | nM | Open TG-GATES in vivo data: Organ Weight |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 9.1 | nM | 25801151 |
NPT2 | Others | Unspecified | Ratio Ki | = | 14.1 | 21980963 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.1 | nM | 19301902 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 89.6 | nM | 20055418 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 37 | nM | 20143840 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Ratio | = | 0.74 | 23252603 | |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 6.53 | umol/kg | 10.6019/CHEMBL1201861 |
NPT2 | Others | Unspecified | Ratio Ki | = | 6 | 10.6019/CHEMBL1201861 | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 3800 | nM | 23914900 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | IC50 | = | 2.77 | nM | 22537362 |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 9000 | nM | 22537362 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 33 | mg/kg | 22360639 |
NPT2 | Others | Unspecified | Ratio Ki | = | 10 | PubChem BioAssay data set | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 31.62 | nM | 16499322 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.1 | 9213587 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.512 | nM | 18077363 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12.59 | nM | 18077363 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 1.9 | nM | 18524584 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.2 | nM | 16180824 |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 14689.2 | nM | 10.1007/s00044-011-9965-x |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 110 | nM | DrugMatrix in vivo data: Pathology |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.7 | nM | 18329753 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 2 | nM | 23631483 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 2.48 | nM | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.28 | nM | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.3 | nM | 24863745 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | 24863745 |
NPT2 | Others | Unspecified | Ratio | = | 6.8 | 25464882 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.28 | nM | 25464882 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 52.4 | nM | 22506638 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 16.1 | nM | 19585998 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 9.1 | nM | 19585998 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 23 | nM | 11325240 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 24.5 | nM | 7901341 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12.4 | nM | 23368996 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 50.12 | nM | 9644066 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 13.3 | nM | 16441065 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 26226070 |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 58047.9 | nM | 18044832 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 17685651 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 152.2 | nM | 16499318 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 4.5 | nM | 20430633 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 31.62 | nM | 19928902 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 94.5 | nM | 19928902 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.1 | nM | 16168652 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 13.3 | nM | 22148427 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 17 | nM | 10447950 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 1.6 | umol/kg | 18183025 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 3.7 | 18183025 | |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | 17850214 | ||
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 89125.1 | nM | 23398362 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Inhibition | = | 70 | % | 23398362 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.7 | nM | 23398362 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 45.59 | nM | 23260578 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 20 | nM | 18077363 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 9200 | nM | 7852999 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2 | nM | 20155971 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 6.31 | nM | 18077173 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 15104491 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 9.2 | nM | 12880316 |
NPT2 | Others | Unspecified | EC50 | = | 47 | nM | 25625705 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 50.12 | nM | 12617583 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | 12088422 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.23 | umol/kg | 10075783 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 13 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 16481.6 | nM | 22316191 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.0017 | umol/kg | 22264170 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 20 | nM | 20185316 |
NPT2 | Others | Unspecified | Ki | = | 1.8 | nM | 27043269 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Inhibition | = | 27 | % | PubChem BioAssay data set |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | IC50 | = | 430 | nM | 17698630 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 3802 | nM | 19114678 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 2.04 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | Ratio Ki | = | 10 | 12086499 | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 23099.9 | nM | 19897363 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | IC50 | = | 3.4 | nM | 18183025 |
NPT3955 | Individual Protein | Cannabinoid CB2 receptor | Rattus norvegicus | IC50 | = | 2200 | nM | 18183025 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 16 | nM | 18077363 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 140 | nM | DrugMatrix in vivo data: Biochemistry |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.9 | nM | DrugMatrix in vivo data: Biochemistry |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 2.5 | nM | 9213587 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | EC50 | = | 10 | nM | 25437304 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 98 | % | 25437304 |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 8000 | nM | 16643047 |
NPT1362 | Protein Family | Cannabinoid receptor | Homo sapiens | Ratio | = | 10 | 16643047 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 40 | nM | 16643047 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 4 | nM | 16643047 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 14 | nM | 15043420 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.2 | nM | 15043420 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 7 | nM | 15043420 |
NPT1169 | Individual Protein | Cannabinoid CB2 receptor | Mus musculus | Ki | = | 6 | nM | 15043420 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | IC50 | = | 1.1 | nM | 15043420 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.1 | 8308864 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 9.1 | nM | 8308864 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 70 | nM | 20100877 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 19223615 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 9.2 | nM | 19223615 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Inhibition | = | 70 | % | 16472241 |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | 18494522 | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 36.2 | nM | 18494522 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 4.6 | nM | 17822299 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 14640515 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | IC50 | = | 5.56 | nM | 12502324 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 33 | mg/kg | 10924166 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.25 | mg/kg | 10924166 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | Inhibition | = | -35 | % | 10924166 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Inhibition | = | 81.7 | % | 25918997 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Inhibition | = | 58 | % | 25918997 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Inhibition | = | 14.1 | % | 25918997 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 45.6 | nM | 18052327 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 1.6 | nM | 18198839 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 20 | nM | 18198839 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 74 | % | 19489596 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 3802 | nM | 18088097 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 22365754 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 16792409 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 24.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Ratio Ki | = | 2.77 | 12762820 | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Activity | = | 3.1 | nmol | 20429578 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 1.585 | nM | 13678412 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 13.3 | nM | 17485504 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 13.18 | nM | 18578517 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.3 | nM | 18578517 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.288 | nM | 18578517 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | EC50 | = | 204 | nM | 22037378 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | EC50 | = | 1450 | nM | DrugMatrix in vitro pharmacology data |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.94 | umol/kg | PubChem BioAssay data set |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 28 | umol/kg | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 0.39 | nM | 23398362 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 37.6 | nM | 23398362 |
NPT1169 | Individual Protein | Cannabinoid CB2 receptor | Mus musculus | Activity | = | 56 | % | 23398362 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 21 | nM | 10425121 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 9.2 | nM | 12502334 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 14.4 | nM | 22264149 |
NPT2 | Others | Unspecified | Potency | 25929 | nM | 22283497 | ||
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 2511.9 | nM | 11929285 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 50 | % | 24063582 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 36 | nM | 16962325 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | IC50 | = | 8.9 | nM | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 86 | nM | 19715320 |
NPT3955 | Individual Protein | Cannabinoid CB2 receptor | Rattus norvegicus | Ki | = | 7.58 | nM | 19715320 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Activity | = | 113 | % | 12502328 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.9 | nM | 23501116 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 127.8 | % | 25763602 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 9.9 | nM | 12027766 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Activity | = | 0.69 | nmol | 20598881 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Activity | = | 1.27 | nmol | 20598881 |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 20587.8 | nM | 12762790 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ratio | = | 1 | PubChem BioAssay data set | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 1760 | nM | PubChem BioAssay data set |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 16.1 | nM | 23647825 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12.59 | nM | 23145884 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.512 | nM | 19008110 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 15104488 |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 19952.6 | nM | 17125236 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 6.06 | nM | 16792412 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.3 | nM | 17896816 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 112 | nM | 24251417 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.512 | nM | 19334707 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12.59 | nM | 19334707 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 59 | nM | 23206866 |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 15003 | nM | 23206866 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.7 | nM | 8984155 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | 10843574 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 13.18 | nM | 88001 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 0.47 | nM | 17279798 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 45 | nM | 17253859 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 199 | nM | 17253859 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 15 | nM | 17253859 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 12 | nM | 2128517 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 15.6 | nM | 20146503 |
NPT1362 | Protein Family | Cannabinoid receptor | Homo sapiens | Ki | = | 24 | nM | 24601675 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 46 | nM | 17958396 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.3 | nM | 25763602 |
NPT2 | Others | Unspecified | Ratio Ki | = | 2.7 | 23385212 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 24.6 | nM | 20550123 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 1.288 | nM | 20373816 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 18180356 |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | 18779359 | |
NPT2 | Others | Unspecified | Ratio Ki | = | 6.8 | 19001116 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.28 | nM | Open TG-GATES in vivo data: Hematology |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 1.9 | nM | Open TG-GATES in vivo data: Hematology |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | Open TG-GATES in vivo data: Hematology |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 0.45 | nM | Open TG-GATES in vivo data: Hematology |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2 | nM | DrugMatrix in vivo data: Biochemistry |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 912010839.4 | nM | 24126094 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Activity | = | 207.1 | % | 25735399 |
NPT2 | Others | Unspecified | Potency | 29081 | nM | 18363379 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 10 | nM | 18396904 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.7 | nM | 11754602 |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 6 | nM | 8377017 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 52.4 | nM | 25442304 |
NPT2 | Others | Unspecified | Ratio Ki | = | 2.3 | 18442289 | ||
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 316.23 | nM | 17844994 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 2.1 | nM | 17844994 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 63.1 | nM | 17844994 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 15.6 | nM | 20144865 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.73 | nM | 16872140 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC329631 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8186 | Intermediate Similarity | NPC49547 |
0.817 | Intermediate Similarity | NPC74575 |
0.8114 | Intermediate Similarity | NPC39370 |
0.8106 | Intermediate Similarity | NPC473186 |
0.7991 | Intermediate Similarity | NPC264176 |
0.7991 | Intermediate Similarity | NPC208522 |
0.7982 | Intermediate Similarity | NPC472099 |
0.7965 | Intermediate Similarity | NPC470018 |
0.7909 | Intermediate Similarity | NPC472098 |
0.7904 | Intermediate Similarity | NPC474688 |
0.79 | Intermediate Similarity | NPC470020 |
0.789 | Intermediate Similarity | NPC270515 |
0.7888 | Intermediate Similarity | NPC470022 |
0.7863 | Intermediate Similarity | NPC148889 |
0.7857 | Intermediate Similarity | NPC288987 |
0.7851 | Intermediate Similarity | NPC478078 |
0.7842 | Intermediate Similarity | NPC53534 |
0.7832 | Intermediate Similarity | NPC216612 |
0.7743 | Intermediate Similarity | NPC225279 |
0.7724 | Intermediate Similarity | NPC132385 |
0.7724 | Intermediate Similarity | NPC152620 |
0.7703 | Intermediate Similarity | NPC187501 |
0.7696 | Intermediate Similarity | NPC257851 |
0.7692 | Intermediate Similarity | NPC470017 |
0.7675 | Intermediate Similarity | NPC144452 |
0.7668 | Intermediate Similarity | NPC94157 |
0.7642 | Intermediate Similarity | NPC322482 |
0.7637 | Intermediate Similarity | NPC475844 |
0.7634 | Intermediate Similarity | NPC39500 |
0.7621 | Intermediate Similarity | NPC208084 |
0.7619 | Intermediate Similarity | NPC157931 |
0.7605 | Intermediate Similarity | NPC72905 |
0.7602 | Intermediate Similarity | NPC185197 |
0.7577 | Intermediate Similarity | NPC131885 |
0.7557 | Intermediate Similarity | NPC472111 |
0.7531 | Intermediate Similarity | NPC67401 |
0.7521 | Intermediate Similarity | NPC475253 |
0.752 | Intermediate Similarity | NPC227824 |
0.7511 | Intermediate Similarity | NPC471762 |
0.7511 | Intermediate Similarity | NPC66777 |
0.7511 | Intermediate Similarity | NPC274640 |
0.7511 | Intermediate Similarity | NPC132642 |
0.75 | Intermediate Similarity | NPC184408 |
0.75 | Intermediate Similarity | NPC142385 |
0.75 | Intermediate Similarity | NPC471304 |
0.748 | Intermediate Similarity | NPC478083 |
0.7479 | Intermediate Similarity | NPC101350 |
0.7467 | Intermediate Similarity | NPC146418 |
0.7466 | Intermediate Similarity | NPC475774 |
0.746 | Intermediate Similarity | NPC191489 |
0.7459 | Intermediate Similarity | NPC137353 |
0.7457 | Intermediate Similarity | NPC21638 |
0.7454 | Intermediate Similarity | NPC475190 |
0.7449 | Intermediate Similarity | NPC258048 |
0.7447 | Intermediate Similarity | NPC474701 |
0.7446 | Intermediate Similarity | NPC210434 |
0.7437 | Intermediate Similarity | NPC235685 |
0.7426 | Intermediate Similarity | NPC253675 |
0.7412 | Intermediate Similarity | NPC152768 |
0.7412 | Intermediate Similarity | NPC148183 |
0.741 | Intermediate Similarity | NPC315634 |
0.741 | Intermediate Similarity | NPC100734 |
0.741 | Intermediate Similarity | NPC88923 |
0.7406 | Intermediate Similarity | NPC258480 |
0.7403 | Intermediate Similarity | NPC280799 |
0.7401 | Intermediate Similarity | NPC236668 |
0.7398 | Intermediate Similarity | NPC244543 |
0.7388 | Intermediate Similarity | NPC473188 |
0.7386 | Intermediate Similarity | NPC124300 |
0.7385 | Intermediate Similarity | NPC472116 |
0.7382 | Intermediate Similarity | NPC473449 |
0.7382 | Intermediate Similarity | NPC179287 |
0.7373 | Intermediate Similarity | NPC260434 |
0.7373 | Intermediate Similarity | NPC476999 |
0.7368 | Intermediate Similarity | NPC146976 |
0.7366 | Intermediate Similarity | NPC53344 |
0.7366 | Intermediate Similarity | NPC310618 |
0.7359 | Intermediate Similarity | NPC323969 |
0.7357 | Intermediate Similarity | NPC38237 |
0.7357 | Intermediate Similarity | NPC474428 |
0.7357 | Intermediate Similarity | NPC26679 |
0.7355 | Intermediate Similarity | NPC291609 |
0.7354 | Intermediate Similarity | NPC470930 |
0.7348 | Intermediate Similarity | NPC96321 |
0.7347 | Intermediate Similarity | NPC165964 |
0.7347 | Intermediate Similarity | NPC26543 |
0.7345 | Intermediate Similarity | NPC199667 |
0.7342 | Intermediate Similarity | NPC469554 |
0.7339 | Intermediate Similarity | NPC205372 |
0.7339 | Intermediate Similarity | NPC122436 |
0.7339 | Intermediate Similarity | NPC318068 |
0.7336 | Intermediate Similarity | NPC161801 |
0.7336 | Intermediate Similarity | NPC66210 |
0.7333 | Intermediate Similarity | NPC287208 |
0.7331 | Intermediate Similarity | NPC278525 |
0.7331 | Intermediate Similarity | NPC24019 |
0.733 | Intermediate Similarity | NPC11017 |
0.7325 | Intermediate Similarity | NPC476287 |
0.7321 | Intermediate Similarity | NPC45190 |
0.7319 | Intermediate Similarity | NPC140296 |
0.7319 | Intermediate Similarity | NPC473185 |
0.7311 | Intermediate Similarity | NPC22481 |
0.7311 | Intermediate Similarity | NPC474798 |
0.7301 | Intermediate Similarity | NPC473181 |
0.7301 | Intermediate Similarity | NPC469589 |
0.7288 | Intermediate Similarity | NPC314954 |
0.7288 | Intermediate Similarity | NPC476997 |
0.7281 | Intermediate Similarity | NPC473180 |
0.728 | Intermediate Similarity | NPC129897 |
0.7269 | Intermediate Similarity | NPC196718 |
0.7265 | Intermediate Similarity | NPC295898 |
0.7265 | Intermediate Similarity | NPC51388 |
0.7262 | Intermediate Similarity | NPC230683 |
0.7258 | Intermediate Similarity | NPC329982 |
0.7257 | Intermediate Similarity | NPC476998 |
0.7257 | Intermediate Similarity | NPC470931 |
0.7257 | Intermediate Similarity | NPC82548 |
0.7257 | Intermediate Similarity | NPC476996 |
0.7253 | Intermediate Similarity | NPC198503 |
0.725 | Intermediate Similarity | NPC108342 |
0.725 | Intermediate Similarity | NPC477549 |
0.7249 | Intermediate Similarity | NPC324361 |
0.7244 | Intermediate Similarity | NPC300156 |
0.7238 | Intermediate Similarity | NPC141053 |
0.7232 | Intermediate Similarity | NPC245816 |
0.7232 | Intermediate Similarity | NPC476138 |
0.7229 | Intermediate Similarity | NPC305984 |
0.7227 | Intermediate Similarity | NPC245916 |
0.7225 | Intermediate Similarity | NPC185782 |
0.722 | Intermediate Similarity | NPC472061 |
0.722 | Intermediate Similarity | NPC189903 |
0.722 | Intermediate Similarity | NPC182907 |
0.7217 | Intermediate Similarity | NPC118228 |
0.7215 | Intermediate Similarity | NPC476994 |
0.7215 | Intermediate Similarity | NPC311906 |
0.7213 | Intermediate Similarity | NPC75179 |
0.7212 | Intermediate Similarity | NPC249583 |
0.7211 | Intermediate Similarity | NPC284685 |
0.7202 | Intermediate Similarity | NPC477066 |
0.7198 | Intermediate Similarity | NPC473041 |
0.7197 | Intermediate Similarity | NPC475720 |
0.7197 | Intermediate Similarity | NPC101543 |
0.7197 | Intermediate Similarity | NPC102593 |
0.7197 | Intermediate Similarity | NPC474192 |
0.7193 | Intermediate Similarity | NPC290689 |
0.7191 | Intermediate Similarity | NPC94842 |
0.7189 | Intermediate Similarity | NPC242928 |
0.7174 | Intermediate Similarity | NPC232225 |
0.7172 | Intermediate Similarity | NPC478081 |
0.716 | Intermediate Similarity | NPC303374 |
0.716 | Intermediate Similarity | NPC41501 |
0.7155 | Intermediate Similarity | NPC477112 |
0.7155 | Intermediate Similarity | NPC293151 |
0.7149 | Intermediate Similarity | NPC476995 |
0.7149 | Intermediate Similarity | NPC174758 |
0.7143 | Intermediate Similarity | NPC194740 |
0.7143 | Intermediate Similarity | NPC16066 |
0.7137 | Intermediate Similarity | NPC34770 |
0.7137 | Intermediate Similarity | NPC193238 |
0.7137 | Intermediate Similarity | NPC469439 |
0.7137 | Intermediate Similarity | NPC90875 |
0.7137 | Intermediate Similarity | NPC4687 |
0.7136 | Intermediate Similarity | NPC230403 |
0.713 | Intermediate Similarity | NPC128823 |
0.7126 | Intermediate Similarity | NPC218388 |
0.7125 | Intermediate Similarity | NPC233334 |
0.7119 | Intermediate Similarity | NPC314633 |
0.7119 | Intermediate Similarity | NPC166722 |
0.7118 | Intermediate Similarity | NPC269367 |
0.7118 | Intermediate Similarity | NPC124086 |
0.7108 | Intermediate Similarity | NPC133609 |
0.7107 | Intermediate Similarity | NPC473187 |
0.7102 | Intermediate Similarity | NPC477067 |
0.7102 | Intermediate Similarity | NPC166712 |
0.7102 | Intermediate Similarity | NPC478082 |
0.71 | Intermediate Similarity | NPC271215 |
0.71 | Intermediate Similarity | NPC149471 |
0.7098 | Intermediate Similarity | NPC329793 |
0.7097 | Intermediate Similarity | NPC91868 |
0.7097 | Intermediate Similarity | NPC63971 |
0.7095 | Intermediate Similarity | NPC473105 |
0.7094 | Intermediate Similarity | NPC473179 |
0.7092 | Intermediate Similarity | NPC478045 |
0.7087 | Intermediate Similarity | NPC220337 |
0.7082 | Intermediate Similarity | NPC246658 |
0.7078 | Intermediate Similarity | NPC472112 |
0.7078 | Intermediate Similarity | NPC473183 |
0.7078 | Intermediate Similarity | NPC6786 |
0.7076 | Intermediate Similarity | NPC280272 |
0.7074 | Intermediate Similarity | NPC209769 |
0.7074 | Intermediate Similarity | NPC174672 |
0.7068 | Intermediate Similarity | NPC203373 |
0.7067 | Intermediate Similarity | NPC118511 |
0.7067 | Intermediate Similarity | NPC470586 |
0.7067 | Intermediate Similarity | NPC31930 |
0.7066 | Intermediate Similarity | NPC473184 |
0.7066 | Intermediate Similarity | NPC182222 |
0.7061 | Intermediate Similarity | NPC283117 |
0.7061 | Intermediate Similarity | NPC210296 |
0.7056 | Intermediate Similarity | NPC310211 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC329631 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD6741 | Clinical (unspecified phase) |
0.806 | Intermediate Similarity | NPD6716 | Phase 1 |
0.8054 | Intermediate Similarity | NPD7395 | Discontinued |
0.8 | Intermediate Similarity | NPD3006 | Discontinued |
0.793 | Intermediate Similarity | NPD7994 | Phase 2 |
0.7851 | Intermediate Similarity | NPD7268 | Clinical (unspecified phase) |
0.7838 | Intermediate Similarity | NPD5417 | Clinical (unspecified phase) |
0.7812 | Intermediate Similarity | NPD4429 | Discontinued |
0.7783 | Intermediate Similarity | NPD6567 | Clinical (unspecified phase) |
0.7783 | Intermediate Similarity | NPD5022 | Discontinued |
0.7763 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7763 | Intermediate Similarity | NPD5429 | Discontinued |
0.7753 | Intermediate Similarity | NPD6160 | Clinical (unspecified phase) |
0.7706 | Intermediate Similarity | NPD4952 | Phase 3 |
0.7703 | Intermediate Similarity | NPD5416 | Discontinued |
0.7702 | Intermediate Similarity | NPD7925 | Phase 2 |
0.7702 | Intermediate Similarity | NPD7924 | Phase 2 |
0.7686 | Intermediate Similarity | NPD6247 | Clinical (unspecified phase) |
0.7686 | Intermediate Similarity | NPD8463 | Approved |
0.7679 | Intermediate Similarity | NPD5293 | Phase 2 |
0.7679 | Intermediate Similarity | NPD7538 | Clinical (unspecified phase) |
0.7672 | Intermediate Similarity | NPD6962 | Phase 2 |
0.7635 | Intermediate Similarity | NPD6525 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD3945 | Discontinued |
0.7629 | Intermediate Similarity | NPD5479 | Discontinued |
0.7617 | Intermediate Similarity | NPD7853 | Phase 2 |
0.7615 | Intermediate Similarity | NPD5483 | Clinical (unspecified phase) |
0.7607 | Intermediate Similarity | NPD4373 | Phase 2 |
0.7598 | Intermediate Similarity | NPD2285 | Clinical (unspecified phase) |
0.7588 | Intermediate Similarity | NPD5850 | Phase 3 |
0.7576 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7558 | Intermediate Similarity | NPD4987 | Clinical (unspecified phase) |
0.7543 | Intermediate Similarity | NPD3259 | Approved |
0.7523 | Intermediate Similarity | NPD7452 | Approved |
0.7523 | Intermediate Similarity | NPD7453 | Approved |
0.7522 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.7511 | Intermediate Similarity | NPD7180 | Phase 3 |
0.7511 | Intermediate Similarity | NPD4958 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6568 | Discontinued |
0.749 | Intermediate Similarity | NPD6790 | Phase 1 |
0.749 | Intermediate Similarity | NPD7417 | Discontinued |
0.7489 | Intermediate Similarity | NPD7031 | Phase 1 |
0.7489 | Intermediate Similarity | NPD2433 | Clinical (unspecified phase) |
0.7479 | Intermediate Similarity | NPD5801 | Clinical (unspecified phase) |
0.746 | Intermediate Similarity | NPD7708 | Approved |
0.7449 | Intermediate Similarity | NPD8102 | Discontinued |
0.7438 | Intermediate Similarity | NPD8100 | Phase 3 |
0.7435 | Intermediate Similarity | NPD6242 | Discontinued |
0.7424 | Intermediate Similarity | NPD5632 | Approved |
0.7414 | Intermediate Similarity | NPD7547 | Clinical (unspecified phase) |
0.7411 | Intermediate Similarity | NPD7467 | Discontinued |
0.741 | Intermediate Similarity | NPD7803 | Approved |
0.7409 | Intermediate Similarity | NPD6961 | Discontinued |
0.7395 | Intermediate Similarity | NPD5891 | Approved |
0.7385 | Intermediate Similarity | NPD5512 | Phase 3 |
0.7379 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7375 | Intermediate Similarity | NPD2921 | Clinical (unspecified phase) |
0.7366 | Intermediate Similarity | NPD5488 | Discontinued |
0.7362 | Intermediate Similarity | NPD7710 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD2951 | Discontinued |
0.7347 | Intermediate Similarity | NPD5482 | Discontinued |
0.7347 | Intermediate Similarity | NPD8101 | Phase 3 |
0.7339 | Intermediate Similarity | NPD4418 | Discontinued |
0.7339 | Intermediate Similarity | NPD8049 | Phase 2 |
0.7277 | Intermediate Similarity | NPD3946 | Clinical (unspecified phase) |
0.7265 | Intermediate Similarity | NPD7868 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD5256 | Discontinued |
0.7253 | Intermediate Similarity | NPD7556 | Discontinued |
0.7244 | Intermediate Similarity | NPD3507 | Phase 2 |
0.7244 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7231 | Intermediate Similarity | NPD8016 | Phase 3 |
0.7231 | Intermediate Similarity | NPD8017 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD6393 | Clinical (unspecified phase) |
0.722 | Intermediate Similarity | NPD7566 | Clinical (unspecified phase) |
0.722 | Intermediate Similarity | NPD4368 | Phase 2 |
0.7217 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7211 | Intermediate Similarity | NPD7955 | Approved |
0.7211 | Intermediate Similarity | NPD7956 | Approved |
0.721 | Intermediate Similarity | NPD7678 | Clinical (unspecified phase) |
0.7207 | Intermediate Similarity | NPD2778 | Approved |
0.7205 | Intermediate Similarity | NPD5866 | Approved |
0.7205 | Intermediate Similarity | NPD7069 | Discontinued |
0.7203 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7203 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7203 | Intermediate Similarity | NPD3263 | Phase 3 |
0.7203 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7189 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7185 | Intermediate Similarity | NPD8052 | Clinical (unspecified phase) |
0.7185 | Intermediate Similarity | NPD1659 | Phase 1 |
0.7178 | Intermediate Similarity | NPD3250 | Phase 1 |
0.7169 | Intermediate Similarity | NPD6569 | Phase 2 |
0.7167 | Intermediate Similarity | NPD6974 | Phase 3 |
0.7165 | Intermediate Similarity | NPD6456 | Discontinued |
0.7163 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD3925 | Approved |
0.716 | Intermediate Similarity | NPD8247 | Approved |
0.716 | Intermediate Similarity | NPD8246 | Approved |
0.7155 | Intermediate Similarity | NPD4989 | Phase 2 |
0.7154 | Intermediate Similarity | NPD6460 | Clinical (unspecified phase) |
0.7149 | Intermediate Similarity | NPD3477 | Phase 2 |
0.7149 | Intermediate Similarity | NPD3478 | Clinical (unspecified phase) |
0.7149 | Intermediate Similarity | NPD6550 | Discontinued |
0.7143 | Intermediate Similarity | NPD4948 | Discontinued |
0.7143 | Intermediate Similarity | NPD3257 | Approved |
0.7125 | Intermediate Similarity | NPD4885 | Approved |
0.7118 | Intermediate Similarity | NPD3392 | Approved |
0.7118 | Intermediate Similarity | NPD1166 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD5914 | Approved |
0.7115 | Intermediate Similarity | NPD6228 | Discontinued |
0.7113 | Intermediate Similarity | NPD5924 | Discontinued |
0.7112 | Intermediate Similarity | NPD3394 | Approved |
0.7112 | Intermediate Similarity | NPD3393 | Approved |
0.7112 | Intermediate Similarity | NPD3389 | Approved |
0.7111 | Intermediate Similarity | NPD2779 | Approved |
0.7105 | Intermediate Similarity | NPD6593 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.7094 | Intermediate Similarity | NPD3258 | Approved |
0.7094 | Intermediate Similarity | NPD7404 | Approved |
0.7094 | Intermediate Similarity | NPD7194 | Discontinued |
0.7093 | Intermediate Similarity | NPD5459 | Phase 2 |
0.7087 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7087 | Intermediate Similarity | NPD7703 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD7688 | Phase 1 |
0.708 | Intermediate Similarity | NPD2121 | Clinical (unspecified phase) |
0.7076 | Intermediate Similarity | NPD6995 | Phase 1 |
0.707 | Intermediate Similarity | NPD4203 | Approved |
0.707 | Intermediate Similarity | NPD4204 | Approved |
0.7064 | Intermediate Similarity | NPD7858 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD5640 | Discontinued |
0.7056 | Intermediate Similarity | NPD8358 | Approved |
0.7054 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7047 | Intermediate Similarity | NPD5116 | Phase 1 |
0.7047 | Intermediate Similarity | NPD6531 | Approved |
0.7047 | Intermediate Similarity | NPD6530 | Approved |
0.7033 | Intermediate Similarity | NPD7022 | Phase 2 |
0.7031 | Intermediate Similarity | NPD4894 | Discontinued |
0.7031 | Intermediate Similarity | NPD5658 | Approved |
0.7029 | Intermediate Similarity | NPD4328 | Approved |
0.7028 | Intermediate Similarity | NPD4369 | Phase 2 |
0.7027 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD6223 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD5040 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD6654 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD6293 | Clinical (unspecified phase) |
0.7012 | Intermediate Similarity | NPD1867 | Approved |
0.7012 | Intermediate Similarity | NPD1505 | Phase 2 |
0.7009 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7004 | Intermediate Similarity | NPD5450 | Discontinued |
0.7 | Intermediate Similarity | NPD3986 | Discontinued |
0.7 | Intermediate Similarity | NPD5559 | Phase 2 |
0.6996 | Remote Similarity | NPD7872 | Phase 2 |
0.6991 | Remote Similarity | NPD6321 | Discontinued |
0.6986 | Remote Similarity | NPD1033 | Clinical (unspecified phase) |
0.6986 | Remote Similarity | NPD1034 | Phase 3 |
0.6984 | Remote Similarity | NPD2311 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD4353 | Phase 2 |
0.6983 | Remote Similarity | NPD3815 | Phase 1 |
0.6983 | Remote Similarity | NPD7797 | Approved |
0.6983 | Remote Similarity | NPD3816 | Phase 1 |
0.6983 | Remote Similarity | NPD7796 | Approved |
0.6976 | Remote Similarity | NPD7921 | Approved |
0.6976 | Remote Similarity | NPD7206 | Clinical (unspecified phase) |
0.6975 | Remote Similarity | NPD7279 | Phase 2 |
0.6975 | Remote Similarity | NPD7278 | Phase 2 |
0.6971 | Remote Similarity | NPD7589 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD6643 | Discontinued |
0.6964 | Remote Similarity | NPD6769 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD6988 | Phase 1 |
0.6963 | Remote Similarity | NPD5603 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD4881 | Clinical (unspecified phase) |
0.696 | Remote Similarity | NPD7013 | Phase 3 |
0.696 | Remote Similarity | NPD6172 | Clinical (unspecified phase) |
0.696 | Remote Similarity | NPD7012 | Phase 3 |
0.6957 | Remote Similarity | NPD2510 | Approved |
0.6957 | Remote Similarity | NPD2509 | Approved |
0.6955 | Remote Similarity | NPD6494 | Phase 2 |
0.6955 | Remote Similarity | NPD6608 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD7025 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD3763 | Approved |
0.6949 | Remote Similarity | NPD7203 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD6770 | Approved |
0.6948 | Remote Similarity | NPD8359 | Phase 2 |
0.6947 | Remote Similarity | NPD4500 | Approved |
0.6947 | Remote Similarity | NPD4501 | Approved |
0.6946 | Remote Similarity | NPD7586 | Clinical (unspecified phase) |
0.6943 | Remote Similarity | NPD6245 | Phase 2 |
0.6943 | Remote Similarity | NPD5601 | Phase 2 |
0.6943 | Remote Similarity | NPD3003 | Approved |
0.694 | Remote Similarity | NPD5475 | Discontinued |
0.6936 | Remote Similarity | NPD5443 | Clinical (unspecified phase) |
0.6934 | Remote Similarity | NPD7690 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD7889 | Clinical (unspecified phase) |
0.6932 | Remote Similarity | NPD6475 | Phase 2 |
0.6923 | Remote Similarity | NPD5902 | Approved |
0.6923 | Remote Similarity | NPD5903 | Approved |
0.6917 | Remote Similarity | NPD7603 | Discontinued |
0.6914 | Remote Similarity | NPD5867 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD5151 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD3746 | Discontinued |
Molecular Weight:   | 426.19 |
ALogP:   | -0.0869 |
MLogP:   | 3.88 |
XLogP:   | 5.935 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 43.7 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 0 |
# Rings:   | 6 |
# Heavy Atoms:   | 32 |